These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis. Zolotov D; Wagner S; Kalb K; Bunia J; Heibges A; Klingel R J Clin Apher; 2012; 27(2):99-105. PubMed ID: 22267052 [TBL] [Abstract][Full Text] [Related]
10. [Refsum syndrome, heredopathia atactica polyneuritiformis in the view of the otolaryngologist (author's transl)]. Feldmann H Laryngol Rhinol Otol (Stuttg); 1981 May; 60(5):235-40. PubMed ID: 6164893 [TBL] [Abstract][Full Text] [Related]
11. Refsum disease: the presentation and ophthalmic aspects of Refsum disease in a series of 23 patients. Claridge KG; Gibberd FB; Sidey MC Eye (Lond); 1992; 6 ( Pt 4)():371-5. PubMed ID: 1282471 [TBL] [Abstract][Full Text] [Related]
12. Phytanic Acid Intake and Lifestyle Modifications on Quality of Life in Individuals with Adult Refsum Disease: A Retrospective Survey Analysis. Li JJ; Kim JJ; Nausheen F Nutrients; 2023 May; 15(11):. PubMed ID: 37299514 [TBL] [Abstract][Full Text] [Related]
19. Treatable forms of retinitis pigmentosa associated with systemic neurological disorders. Grant CA; Berson EL Int Ophthalmol Clin; 2001; 41(1):103-10. PubMed ID: 11198137 [TBL] [Abstract][Full Text] [Related]
20. [Heredopathia atactica polyneuritiformis: phytanic acid storage disease (Refsum's syndrome). Effect of diet therapy on retinal and cochlear changes]. Refsum S Neurol Neurochir Pol; 1984; 18(1):1-4. PubMed ID: 6203044 [No Abstract] [Full Text] [Related] [Next] [New Search]